1 unknown. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Unknown 1 |
Follow LiuYing: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Cadonilimab as Neoadjuvant Therapy in Resectable Stage II-III MSI-H/dMMR Colorectal Cancer Cadonilimab (®), a PD-1/CTLA-4 bi-specific antibody - Colorectal Cancer, Mismatch Repair-deficient (dMMR) | Phase 2 | Unknown | LiuYing | 22 | 2023-06-20 | 2023-06-22 |
Colorectal Neoplasms (1) · Turcot syndrome (1)
China (1)
Ying Liu, MD (1)